7.42
0.27%
-0.02
After Hours:
7.45
0.03
+0.40%
Editas Medicine Inc Stock (EDIT) Forecast
The Editas Medicine Inc (EDIT) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $17.42, representing a +134.76% increase from the current price of $7.42. The highest analyst price target is $25.10, and the lowest is $9.7385.
Based on our technical indicators, the current sentiment is bearish but EDIT could still hit $31.25 in 2025. This might not be a good time to consider opening new positions on EDIT, as trading bearish markets can be challenging and may result in losses.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EDIT Price Target
Average 17.42
(+134.76% Upside)
Editas Medicine Inc Stock (EDIT) Technical Analysis Forecast
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 40.00 | Neutral |
STOCH(9,6) | 9.4758 | Buy |
STOCHRSI(14) | 21.20 | Neutral |
MACD(12,26) | -0.333 | Sell |
ADX(14) | 17.66 | Neutral |
William %R | -90.27 | Buy |
CCI(14) | -79.91 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
7.626
Sell
|
7.6855
Sell
|
MA20 |
8.3645
Sell
|
8.0046
Sell
|
MA50 |
8.1042
Sell
|
8.3277
Sell
|
MA100 |
8.9615
Sell
|
8.5098
Sell
|
MA200 |
8.5703
Sell
|
8.6346
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
Long-term EDIT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Our analysts are offering long term price forecasts for Editas Medicine Inc In 2050, the median target price for EDIT is $20.77, with a high estimate of $22.52 and a low estimate of $15.31. The median estimate represents a +179.88% increase from the last price of $7.42. Below is our long term EDIT Price forecast table with detailed price target for each year.
Year | Average | Low | High | Change from today's price |
---|---|---|---|---|
2024 | $13.29 | $8.761 | $18.06 | +79.17% |
2025 | $18.54 | $4.8992 | $31.25 | +149.88% |
2026 | $60.64 | $18.68 | $91.69 | +717.22% |
2027 | $8.2941 | $2.8059 | $64.91 | +11.78% |
2028 | $3.8907 | $0.4097 | $13.34 | +-47.56% |
2029 | $5.4998 | $0.1303 | $7.7546 | +-25.88% |
2030 | $0.0731 | $0.187 | $15.83 | +-99.02% |
2035 | $4.2234 | $0.0557 | $10.06 | +-43.08% |
2040 | $15.11 | $5.2886 | $20.13 | +103.62% |
2045 | $14.16 | $9.3516 | $16.54 | +90.78% |
2050 | $20.77 | $15.31 | $22.52 | +179.88% |
Editas Medicine Inc Stock (EDIT) Year by Year Forecast
Editas Medicine Inc Stock (EDIT) Price Forecast for 2024
For Editas Medicine Inc Stock (EDIT) price forecast for 2024, the average price target for Editas Medicine Inc Stock is $13.41 with a high forecast of $18.06 and a low forecast of $8.761. The average EDIT price prediction of 2024 represents a +80.74% increase from the last price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
April, 2024 | $15.98 | $12.22 | $17.82 | +115.33% |
May, 2024 | $14.79 | $13.26 | $18.06 | +99.30% |
June, 2024 | $10.68 | $10.60 | $16.02 | +43.99% |
July, 2024 | $14.25 | $10.34 | $15.36 | +92.00% |
August, 2024 | $15.69 | $13.64 | $17.24 | +111.41% |
September, 2024 | $14.97 | $12.82 | $16.48 | +101.69% |
October, 2024 | $12.74 | $12.60 | $17.14 | +71.64% |
November, 2024 | $10.28 | $9.7385 | $13.68 | +38.49% |
December, 2024 | $13.29 | $10.16 | $14.07 | +79.17% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2025
Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $18.08 in 2025, with a high prediction of $31.25 and a low estimate of $4.8992. This indicates an +143.62% rise from the last recorded price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $20.38 | $13.08 | $22.39 | +174.73% |
February, 2025 | $19.76 | $19.45 | $23.48 | +166.24% |
March, 2025 | $18.91 | $16.69 | $25.10 | +154.90% |
April, 2025 | $14.72 | $10.89 | $19.00 | +98.44% |
May, 2025 | $10.29 | $4.8992 | $14.17 | +38.74% |
June, 2025 | $14.13 | $9.142 | $17.52 | +90.47% |
July, 2025 | $21.17 | $12.44 | $21.21 | +185.35% |
August, 2025 | $23.44 | $16.12 | $24.70 | +215.95% |
September, 2025 | $23.47 | $19.60 | $27.95 | +216.33% |
October, 2025 | $26.23 | $20.13 | $31.25 | +253.53% |
November, 2025 | $21.85 | $19.89 | $29.55 | +194.51% |
December, 2025 | $18.54 | $18.48 | $25.50 | +149.88% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2026
The 2026 price forecast for Editas Medicine Inc Stock (EDIT) stands at an average of $55.18. Projections range from a high of $91.69 to a low of $18.68, signifying an +643.69% increase from the previous price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $22.48 | $18.94 | $26.57 | +202.98% |
February, 2026 | $22.95 | $18.68 | $24.46 | +209.32% |
March, 2026 | $75.23 | $21.47 | $88.15 | +913.88% |
April, 2026 | $57.53 | $54.27 | $91.69 | +675.34% |
May, 2026 | $48.33 | $44.59 | $62.22 | +551.36% |
June, 2026 | $32.41 | $27.98 | $48.11 | +336.78% |
July, 2026 | $26.67 | $25.58 | $37.55 | +259.43% |
August, 2026 | $25.30 | $21.42 | $31.55 | +240.94% |
September, 2026 | $28.04 | $24.49 | $31.04 | +277.87% |
October, 2026 | $40.80 | $27.89 | $52.21 | +449.85% |
November, 2026 | $54.98 | $29.91 | $58.71 | +640.93% |
December, 2026 | $60.64 | $49.93 | $65.41 | +717.22% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2027
For 2027, the average price target for Editas Medicine Inc Stock (EDIT) is $33.86, with a high forecast of $64.91 and a low forecast of $2.8059. This indicates an +356.27% increase from the last price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $33.51 | $32.07 | $64.91 | +351.59% |
February, 2027 | $30.26 | $26.87 | $33.60 | +307.80% |
March, 2027 | $24.99 | $24.54 | $34.69 | +236.75% |
April, 2027 | $22.57 | $19.51 | $26.49 | +204.14% |
May, 2027 | $10.93 | $10.89 | $23.58 | +47.24% |
June, 2027 | $8.9758 | $8.8158 | $12.99 | +20.97% |
July, 2027 | $8.9763 | $6.131 | $12.22 | +20.97% |
August, 2027 | $13.22 | $6.8215 | $13.68 | +78.23% |
September, 2027 | $6.3149 | $5.9749 | $14.62 | -14.89% |
October, 2027 | $4.8254 | $2.8202 | $9.0326 | -34.97% |
November, 2027 | $6.7036 | $2.8059 | $7.1763 | -9.66% |
December, 2027 | $8.2941 | $4.8312 | $9.5641 | +11.78% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2028
Editas Medicine Inc Stock (EDIT) is estimated to achieve an average price of $6.8771 in 2028, with a high projection of $13.34 and a low estimate of $0.4097. This suggests an -7.32% fall from the preceding price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $8.1122 | $8.0522 | $13.34 | +9.33% |
February, 2028 | $9.2927 | $7.5451 | $10.02 | +25.24% |
March, 2028 | $5.5332 | $5.2532 | $9.6404 | -25.43% |
April, 2028 | $6.1537 | $4.6061 | $6.7685 | -17.07% |
May, 2028 | $4.2919 | $3.2666 | $7.8514 | -42.16% |
June, 2028 | $2.6024 | $2.4524 | $4.3895 | -64.93% |
July, 2028 | $3.4205 | $1.5203 | $3.6205 | -53.90% |
August, 2028 | $4.071 | $2.8882 | $5.8133 | -45.13% |
September, 2028 | $1.8215 | $1.4715 | $3.8887 | -75.45% |
October, 2028 | $1.6697 | $0.4097 | $2.7442 | -77.50% |
November, 2028 | $3.7302 | $1.6523 | $4.8602 | -49.73% |
December, 2028 | $3.8907 | $2.9831 | $4.6778 | -47.56% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2029
The 2029 price forecast for Editas Medicine Inc Stock (EDIT) is $3.9424 on average, with a high prediction of $7.7546 and a low estimate of $0.1303. This represents an -46.87% decrease from the previous price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $2.7188 | $1.9836 | $6.1659 | -63.36% |
February, 2029 | $3.1593 | $2.7265 | $3.5165 | -57.42% |
March, 2029 | $3.2198 | $2.6646 | $3.917 | -56.61% |
April, 2029 | $2.388 | $2.248 | $3.9604 | -67.82% |
May, 2029 | $0.8985 | $0.8885 | $3.1356 | -87.89% |
June, 2029 | $2.349 | $0.706 | $3.739 | -68.34% |
July, 2029 | $5.2771 | $1.8466 | $6.4571 | -28.88% |
August, 2029 | $2.0253 | $0.1303 | $6.2148 | -72.71% |
September, 2029 | $0.8763 | $0.9805 | $7.531 | -88.19% |
October, 2029 | $0.5375 | $0.6185 | $2.102 | -92.76% |
November, 2029 | $4.0336 | $0.2422 | $4.4983 | -45.64% |
December, 2029 | $5.4998 | $2.3041 | $7.7546 | -25.88% |
Editas Medicine Inc Stock (EDIT) Price Forecast for 2030
Editas Medicine Inc Stock (EDIT) is expected to reach an average price of $8.009 in 2030, with a high forecast of $15.83 and a low forecast of $0.187. This signifies an +7.94% surge from the last price of $7.42.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $4.2609 | $3.2656 | $8.0503 | -42.58% |
February, 2030 | $2.6419 | $0.4319 | $3.9511 | -64.40% |
March, 2030 | $4.4129 | $1.3071 | $5.5229 | -40.53% |
April, 2030 | $5.5106 | $3.8281 | $7.4739 | -25.73% |
May, 2030 | $5.2902 | $3.0944 | $6.7849 | -28.70% |
June, 2030 | $3.1312 | $2.9913 | $7.5007 | -57.80% |
July, 2030 | $1.9413 | $0.187 | $4.1117 | -73.84% |
August, 2030 | $3.8485 | $0.7185 | $4.6285 | -48.13% |
September, 2030 | $13.14 | $3.6537 | $14.03 | +77.15% |
October, 2030 | $12.21 | $9.5358 | $14.14 | +64.50% |
November, 2030 | $9.6968 | $7.4778 | $15.83 | +30.68% |
December, 2030 | $0.0731 | $1.4969 | $9.802 | -99.02% |
Cap:
|
Volume (24h):